These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6256794)

  • 21. Jumping behavior induced by thyrotropin releasing hormone in combination with apomorphine in mice.
    Ushijima I; Yamada K; Noda Y; Furukawa T
    Psychopharmacology (Berl); 1982; 76(1):1-4. PubMed ID: 6281836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of adrenergic, dopaminergic, cholinergic and serotoninergic drugs on plasma prolactin levels in ovariectomized, estrogen-treated rats.
    Lawson DM; Gala RR
    Endocrinology; 1975 Feb; 96(2):313-8. PubMed ID: 234380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of drugs affecting the noradrenergic system on convulsions in the quaking mouse.
    Chermat R; Doaré L; Lachapelle F; Simon P
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Dec; 318(2):94-9. PubMed ID: 6276790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central histaminergic mechanisms in the corticosterone response to clonidine.
    Bugajski J; Gadek-Michalska A; Borycz J; Bugajski AJ
    J Physiol Pharmacol; 1993 Sep; 44(3):303-12. PubMed ID: 8241531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for alpha-adrenergic regulation of episodic growth hormone and prolactin secretion in the undisturbed male rat.
    Terry LC; Martin JB
    Endocrinology; 1981 May; 108(5):1869-73. PubMed ID: 6260466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for a role of alpha-adrenergic mechanisms in regulation of episodic growth hormone secretion in the rat.
    Durand D; Martin JB; Brazeau P
    Endocrinology; 1977 Mar; 100(3):722-8. PubMed ID: 233821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Central cholinergic mechanisms in electrical self-stimulation and in drug-induced tremor in rats.
    Wishart TB; Herberg LJ
    Pharmacol Biochem Behav; 1979 Dec; 11(6):625-9. PubMed ID: 538051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of muscarinic cholinergic involvement in the antinociceptive effects of morphine and clonidine in the mouse.
    Lipman JJ; Spencer PS
    Eur J Pharmacol; 1980 Jun; 64(4):249-58. PubMed ID: 7389822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma corticosterone response to serotonin altering drugs in the 3-day-old rat.
    Grota LJ
    Dev Psychobiol; 1979 Jul; 12(4):399-405. PubMed ID: 37135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional evidence for two stereochemically different alpha-2 adrenoceptors regulating central norepinephrine and serotonin release.
    Raiteri M; Maura G; Versace P
    J Pharmacol Exp Ther; 1983 Mar; 224(3):679-84. PubMed ID: 6298406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypophysectomy alters both 5-hydroxytryptamine- and alpha 2-adrenoceptor-mediated behavioural changes in the rat.
    Heal DJ; O'Shaughnessy KM; Smith SL; Nutt DJ
    Eur J Pharmacol; 1983 Apr; 89(1-2):167-71. PubMed ID: 6305683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent developments in noradrenergic neurotransmission and its relevance to the mechanism of action of certain antihypertensive agents.
    Langer SZ; Cavero I; Massingham R
    Hypertension; 1980; 2(4):372-82. PubMed ID: 6105128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postsynaptic alpha 2-noradrenergic receptors mediate feeding induced by paraventricular nucleus injection of norepinephrine and clonidine.
    Goldman CK; Marino L; Leibowitz SF
    Eur J Pharmacol; 1985 Sep; 115(1):11-9. PubMed ID: 2995083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blockade of nitric oxide formation impairs adrenergic-induced ACTH and corticosterone secretion.
    Bugajski J; Gadek-Michalska A; Głód R; Borycz J; Bugajski AJ
    J Physiol Pharmacol; 1999 Jun; 50(2):327-34. PubMed ID: 10424727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction between norepinephrine and serotonin in the neuroendocrine control of growth hormone release in the rat.
    Conway S; Richardson L; Speciale S; Moherek R; Mauceri H; Krulich L
    Endocrinology; 1990 Feb; 126(2):1022-30. PubMed ID: 1688789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological characterization of presynaptic alpha-adrenoceptors modulating [3H]noradrenaline and [3H]5-hydroxytryptamine release from slices of the hippocampus of the rat.
    Frankhuyzen AL; Mulder AH
    Eur J Pharmacol; 1982 Jun; 81(1):97-106. PubMed ID: 6288401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mianserin attenuates naloxone-precipitated withdrawal signs in rats acutely or chronically dependent upon morphine.
    Neal BS; Sparber SB
    J Pharmacol Exp Ther; 1986 Jan; 236(1):157-65. PubMed ID: 3001281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of the central noradrenergic system in cholinergic stimulation of the pituitary-adrenal response.
    Bugajski J; Borycz J; Gadek-Michalska A
    J Physiol Pharmacol; 1998 Jun; 49(2):285-92. PubMed ID: 9670111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DDT-induced myoclonus: serotonin and alpha noradrenergic interaction.
    Hwang EC; Van Woert MH
    Res Commun Chem Pathol Pharmacol; 1979 Feb; 23(2):257-66. PubMed ID: 37558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adrenergic regulation of the hypothalamic-pituitary-adrenal axis under basal and social stress conditions.
    Bugajski J; Gadek-Michalska A; Ołowska A; Borycz J; Głód R; Bugajski AJ
    J Physiol Pharmacol; 1995 Sep; 46(3):297-312. PubMed ID: 8527811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.